My opinion only of course.It seems to have been a long year,...

My opinion only of course.It seems to have been a long year, however I'm reminded of Leslie's interview on Proactive Investors late last year in which she said that 2022 was a year for consolidation, not for making money. She has been true to her word. I was disappointed at the time, as when I first saw an interview with her and decided it was a great company in which to invest, I bought a very small parcel and around that time found HotCopper. I loved the science but had no idea of the biotech timeline obviously as indicated in my Target 2017. We only had HerVaxx then and it was going to the moon. Anyway, here we are in 2022 and anxiously waiting for the next trading halt which is not for a cap raise, but a lovely deal by a company that has only continued to grow and be led by a magnificent team of managers and scientists.

Hopefully we'll see a media onslaught in the next couple of weeks. We are looking forward to that front page news. I love seeing Leslie's Proactive interviews but I feel they are now preaching to the converted.

My opinion only